republic-os/legislation/us/states/or/2021-regular-session/sb-711.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Relating to gender disparities in cost of pharmaceuticals; and prescribing an effective date.	Requires Department of Consumer and Business Services to study cost differences in hormone replacement drugs used by men and hormone replacement drugs used by women and report findings to Legislative Assembly no later than September 15, 2022.<b> Requires department to keep strictly confidential information submitted in accordance with prescription drug price transparency program that is collected, used or relied upon for study, if information is not already in public domain and is confidential, proprietary or trade secret.</b>	us/states/or	Oregon Legislative Assembly	2021 Regular Session	SB 711	Oregon SB 711 (2021 Regular Session)	bill		enacted	Deb Patterson	8	24	5	2021-01-22T16:29:52+00:00	2021-07-07T18:23:45+00:00	openstates	ocd-bill/49744da0-367c-4935-b140-d9bb782d2389	https://olis.oregonlegislature.gov/liz/2021R1/Measures/Overview/SB711	f06de6d4da4c666cf16581e532e51bb384f8b79fd2d6cc99fe390bf4b159c0e3	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-or

Oregon SB 711 (2021 Regular Session) — Relating to gender disparities in cost of pharmaceuticals; and prescribing an effective date.

Requires Department of Consumer and Business Services to study cost differences in hormone replacement drugs used by men and hormone replacement drugs used by women and report findings to Legislative Assembly no later than September 15, 2022. Requires department to keep strictly confidential information submitted in accordance with prescription drug price transparency program that is collected, used or relied upon for study, if information is not already in public domain and is confidential, proprietary or trade secret.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced (filed) — source
2. Senate Amendments to Introduced (filed) — source
3. A-Engrossed (committee substitute) — source
4. B-Engrossed (committee substitute) — source
5. HHC Amendment -A13 (committee substitute) — source
6. House Amendments to A-Engrossed (committee substitute) — source
7. SHC Amendment -10 (committee substitute) — source
8. Enrolled (enrolled) — source

Votes

• Third reading. Carried by Dexter. Passed. — 46–10 (pass) · lower
• Heard and Reported Out with Amendments — 3–2 (pass) · upper
• Senate concurred in House amendments and repassed bill. — 21–9 (pass) · upper
• Third reading. Carried by Patterson. Passed. — 17–11 (pass) · upper
• Heard and Reported Out with Amendments — 10–0 (pass) · lower

Sponsors

• Deb Patterson — primary (person)
• Andrea Salinas — cosponsor (person)
• James Manning Jr. — cosponsor (person)
• Kate Lieber — cosponsor (person)
• Lew Frederick — cosponsor (person)
• Maxine Dexter — cosponsor (person)
• Rachel Prusak — cosponsor (person)
• Sheri Schouten — cosponsor (person)
• Teresa Alonso Leon — cosponsor (person)
• Wlnsvey Campos — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2021-01-22T16:29:52+00:00 Introduction and first reading. Referred to President's desk. introduction, reading-1, referral-committee
• 2021-01-28T01:02:47+00:00 Referred to Health Care. referral-committee
• 2021-02-22T21:01:00+00:00 Public Hearing held.
• 2021-03-29T20:01:00+00:00 Work Session held.
• 2021-03-31T20:02:00+00:00 Work Session held.
• 2021-04-15T22:07:40+00:00 Recommendation: Do pass with amendments. (Printed A-Eng.) committee-passage-favorable
• 2021-04-19T17:47:44+00:00 Second reading. reading-2
• 2021-04-21T19:23:44+00:00 Third reading. Carried by Patterson. Passed. passage, reading-3
• 2021-04-27T16:54:08+00:00 First reading. Referred to Speaker's desk. introduction, reading-1, referral-committee
• 2021-04-28T02:01:38+00:00 Referred to Health Care. referral-committee
• 2021-05-13T22:16:00+00:00 Public Hearing held.
• 2021-05-18T22:16:00+00:00 Work Session held.
• 2021-05-25T22:17:00+00:00 Work Session held.
• 2021-05-27T21:51:49+00:00 Recommendation: Do pass with amendments and be printed B-Engrossed. committee-passage-favorable
• 2021-06-01T18:17:57+00:00 Second reading. reading-2
• 2021-06-02T23:12:59+00:00 Rules suspended. Carried over to June 3, 2021 Calendar.
• 2021-06-03T22:49:23+00:00 Rules suspended. Carried over to June 7, 2021 Calendar.
• 2021-06-07T23:29:35+00:00 Third reading. Carried by Dexter. Passed. passage, reading-3
• 2021-06-09T18:04:08+00:00 Senate concurred in House amendments and repassed bill.
• 2021-06-14T16:40:06+00:00 President signed. passage
• 2021-06-15T18:52:39+00:00 Speaker signed. passage
• 2021-06-23T17:39:56+00:00 Governor signed. executive-signature
• 2021-07-07T17:05:39+00:00 Chapter 407, 2021 Laws.
• 2021-07-07T18:23:45+00:00 Effective date, September 25, 2021.

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/49744da0-367c-4935-b140-d9bb782d2389. Confidence: reported (aggregated from official Oregon legislature records).